Showing results (191-200 of 629) with videos related to

Sort By:
Pageof 63
Journal of the American College of Cardiology|October 23, 2024
Aspirin Hypersensitivity in Patients With Atherosclerotic Cardiovascular DiseaseMattia Galli, Gabriele Cortellini, Giovanni Occhipinti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 31, 2022
Antiplatelet therapy after percutaneous coronary interventionDominick J Angiolillo, Mattia Galli, Jean-Philippe Collet, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCIRosanne F Vogel, Ronak Delewi, Lina Badimon, et al.
JACC. Cardiovascular Interventions|August 23, 2023
Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) StudyFrancesco Franchi, Fabiana Rollini, Luis Ortega-Paz, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 30, 2022
Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapyMattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Thrombosis and Haemostasis|August 31, 2019
Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT StudyFrancesco Franchi, Fabiana Rollini, Emilio Garcia, et al.
Thrombosis and Haemostasis|January 4, 2022
Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic DiseaseMattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Journal of the American Heart Association|July 2, 2021
Cangrelor: Clinical Data, Contemporary Use, and Future PerspectivesLeonardo De Luca, Philippe Gabriel Steg, Deepak L Bhatt, et al.
Vascular Health and Risk Management|May 14, 2009
Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularizationClarissa Cola, Salvatore Brugaletta, Victoria Martín Yuste, et al.
JACC. Basic to Translational Science|August 22, 2024
Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CADLuis Ortega-Paz, Francesco Franchi, Fabiana Rollini, et al.
Pageof 63